Last night, as April came to a close, pink sheet Coronacrap stock, Cytodyn (CYDY), a favorite of retail investors both in the USA and Germany (Freut mich), released an amended S3 filing with the SEC. (Catch up on Who’s Touting Cytodyn Now and Who’s Suing Cytodyn Now too)
This filing will allow for millions of shares to be dumped on the market. How many millions?
How about 46.4mm shares!
As this is an amendment to a previous registration statement, we can take a look at the old S3, from January 2020, and compare the amounts.
Between January 31 and April 30, the company has increased the amount of stock to be sold by
40.3 30.3mm shares.
And just who are the lucky sellers?
From the January document:
And now the updated list:
One name should immediately stand out to long time readers and fans of biodreck stock promotion scandals. Michael McCarthy. Remember him from the Dream Team Group? In a series of article by Adam Feuerstein at TheStreet.com (now at Stat News) and Richard Pearson (MoxReports), these undisclosed-pay-for-puff-piece article stock promotion schemes were exposed. And the SEC took action concerning these fake posts.
Currently, Cytodyn is the subject of relentless stock promotion, today 1 May, the company is doing a livestream entitled “Wall Street Reporter’s Next Super Stock“.
Being the Next Super Stock isn’t easy. It costs money. How much?
Clients pay $9,500 for 3 month marketing distribution program, which includes featured visibility in SPOTLIGHT, LEADERS, FEATURED STOCKS, NEWSMAKERS, and weekly highlight in e-mail newsletter. Current 3 month clients: BOSQF, CYDY, MDCL, NGTF. Next SuperStock Conference Presenters/ 3 month Premium Visibility distribution: NEXCF $18,500, HOTH $18,500, NGTF $18,500, CYDY $18,500.
Looks like CYDY coughed up $29k for super stock status. And to whom are they paying exactly. Who is behind Wall Street Reporter? A gentleman named Jack Marks.
But he is really Jacob Mestechkin, who has a long history of stock promotion!
And you may also have seen a series of videos hyping Cytodyn and its likely completely ineffective (see NEJM letter here), woefully old, CCR5 entry inhibitor, leronlimab. One was just posted yesterday, 30 April.
The videos (link here if you can stand to watch it without getting sick to your stomach) are slickly produced by an outfit called Proactive Investors. Richard Pearson, one of the writers who exposed filthy stock promotion outfit, Dream Team Group, also exposed Proactive’s shady undisclosed paid promotion tactics. Read that expose here.
Plenty more names on that list of selling stockholders to explore….until then.
THE CONTENT CONTAINED IN THIS BLOG REPRESENTS ONLY THE OPINIONS OF THE AUTHOR. THE AUTHOR MAY HOLD EITHER LONG OR SHORT POSITIONS IN SECURITIES OF VARIOUS COMPANIES DISCUSSED IN THE BLOG. THIS COMMENTARY IN NO WAY CONSTITUTES INVESTMENT ADVICE, AND SHOULD NEVER BE RELIED ON IN MAKING AN INVESTMENT DECISION, EVER. THIS BLOG IS NOT A SOLICITATION OF BUSINESS: ALL INQUIRIES WILL BE IGNORED. THE CONTENT HEREIN IS INTENDED SOLELY FOR THE ENTERTAINMENT OF THE READER, AND THE AUTHOR.